ExxonMobil (XOM) Q4 2025 earnings review

Record Production Meets Price Realization Reality

ExxonMobil achieved a massive operational milestone in Q4, hitting 5.0 million oil-equivalent barrels per day—the highest in over 40 years—driven by the Pioneer integration and record output in Guyana and the Permian. However, volume growth could not fully offset weaker commodity prices. While Revenue of $82.3B beat expectations, Net Income fell 14% YoY to $6.5B. A sharp divergence emerged between segments: Energy Products (Refining) profits surged 80% sequentially, while Chemical Products swung to a $281M loss. Management maintained the $20B annual buyback pace, signaling confidence in cash flow despite the earnings compression.

🐂 Bull Case

Production Records in Advantaged Assets

The growth engine is firing on all cylinders. Net production hit 5.0M boe/d, up ~15% YoY. Advantaged assets (Permian, Guyana, LNG) now comprise 59% of total production, up 7 percentage points YoY. This lowers the corporate breakeven significantly.

Refining Resilience

Energy Products (Refining) proved to be a hedge in Q4, delivering $3.4B in earnings (up 80% vs Q3) due to stronger margins and record North American throughput. This offset weakness in Upstream and Chemicals.

🐻 Bear Case

Chemicals Segment Deterioration

The Chemical Products segment is flashing red, swinging from a $515M profit in 25Q3 to a $281M loss in 25Q4. Weaker industry margins and impairment charges outweighed sales volume records.

Upstream Profit Compression

Despite pumping significantly more oil, Upstream earnings collapsed to $3.5B in Q4 from $6.5B a year ago. Lower crude realizations and higher depreciation (from new volumes) are dragging down the bottom line.

⚖️ Verdict: ⚪

Neutral. Operational execution is flawless (records in Permian/Guyana), but the macro environment is biting back. The loss in Chemicals and the steep drop in Upstream profitability per barrel temper the excitement over volume growth. The 3.5% dividend yield and massive buyback provide a floor, but earnings momentum is currently negative.

Key Themes

CONCERNNEW🔴🔴

Chemicals Segment Swings to Loss

Reversing. The Chemical Products segment has turned into a drag on results. After generating $515M in profit in Q3, the segment posted a $281M loss in Q4. While sales volumes hit a record (21.3M tons), pricing power has evaporated due to weak industry margins and ramp-up costs. This indicates significant oversupply in the global chemicals market.

DRIVER🟢🟢

Advantaged Asset Production Surge

Accelerating. Total production jumped to 5.0M boe/d. The specific growth in 'Advantaged Assets' (Permian, Guyana) is critical—these now make up 59% of the mix. Permian production reached 1.8M boe/d and Guyana nearly 875k gross boe/d. This mix shift lowers the cost of supply, essential for defending margins in a lower-price environment.

CONCERN

Upstream Realizations Dropping

Decelerating. The value of what XOM produces is falling faster than they can grow volumes. U.S. Crude realization dropped from $63.56/bbl in Q3 to $58.57/bbl in Q4. International gas prices also softened. This price effect wiped out ~$2.9B in full-year earnings despite volume gains.

DRIVER🟢

Structural Cost Savings

Stable. The company delivered an additional $3.0B in structural cost savings in 2025, bringing the cumulative total since 2019 to $15.1B. This exceeds the combined savings of all other major IOCs. This discipline is the only reason cash flows remain robust ($52B Operating CF for FY25) amidst falling prices.

THEMENEW

Refining (Energy Products) Volatility

Reversing (Positive). After a weak Q3 ($1.8B earnings), the Energy Products segment rebounded sharply to $3.4B in Q4 (+80% QoQ). Drivers included stronger diesel/gasoline crack spreads and record refinery throughput. This highlights the value of the integrated model—refining absorbed the shock from lower oil prices that hit Upstream.

CONCERN

Baytown Hydrogen & Policy Risk

Uncertain. In prior quarters, management flagged that the Baytown blue hydrogen project might 'slip' or not move forward without clear market-driven incentives (IRA 45V). With the Q4 release emphasizing 'mixed progress' on low carbon initiatives generally, the viability of this flagship project remains a key monitoring point for 2026 capex allocation.

Other KPIs

Shareholder Distributions (FY25)$37.2 Billion

Stable. ExxonMobil returned $37.2B to shareholders in 2025 ($17.2B dividends, $20.0B buybacks). The company reaffirmed its plan to repurchase $20B in shares through 2026. This consistent capital return is the primary thesis for holding the stock during an earnings dip.

Total Debt-to-Capital14.0%

Stable. Up slightly from 13.5% in Q3, but net-debt-to-capital remains pristine at 11.0%. Cash balance ended at $10.7B. The balance sheet remains a fortress, allowing the company to sustain the $20B buyback pace even if oil prices soften further.

ROCE (Return on Capital Employed)9.3%

Decelerating. FY25 ROCE dropped to 9.3% from 12.7% in FY24. While management cites this as 'leading IOCs,' the downward trend reflects the impact of lower commodity prices and the integration of substantial capital assets (Pioneer) that are still ramping up efficiency.

Guidance

FY26 Cash Capital Expenditures$27 - $29 Billion

Stable. The company maintained its capital discipline, guiding for $27-29B in 2026. This suggests no panic cuts despite lower earnings, but also no spending spree. It aligns with the long-term '2030' plan.

Share Repurchases (Through 2026)$20 Billion / year

Stable. Management reiterated the $20B annual buyback target through 2026. At current market cap, this represents a significant yield (~4%) on top of the dividend. This guidance assumes 'reasonable market conditions,' which is code for stable oil prices.

Structural Cost Savings (Cumulative by 2030)$20 Billion

Accelerating. The target for cumulative savings by 2030 remains $20B. With $15.1B already achieved (adding $3B in 2025 alone), the company is well ahead of schedule, providing a margin buffer against inflation.

Key Questions

Chemicals Path to Profitability

With Chemical Products swinging to a $281M loss despite record volumes, is this purely a macro cycle bottom, or are there structural cost issues in the new capacities coming online? When do you expect breakeven?

Upstream Margin Compression

US Upstream earnings fell sequentially ($1.2B to $753M) despite higher production. Besides headline price realization, are you seeing rising unit costs or steeper differentials in the Permian post-Pioneer integration?

Low Carbon Projects FID Status

Given the 'mixed progress' cited in previous quarters regarding Baytown Hydrogen and the current political landscape, is there a specific deadline for FID in 2026 before capital is reallocated elsewhere?

Buyback Sustainability

Free Cash Flow for FY25 was $26.1B. Total distributions were $37.2B. You are effectively using the balance sheet to fund the gap. At what oil price do you reconsider the $20B buyback pace to preserve the balance sheet?